Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents.

[1]  H. Klocker,et al.  Identification of transcription factors associated with castration‐resistance: Is the serum responsive factor a potential therapeutic target? , 2013, The Prostate.

[2]  K. Jeong,et al.  The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion , 2012, Oncogene.

[3]  David H Sherman,et al.  MScreen: an integrated compound management and high-throughput screening data storage and analysis system. , 2012, Journal of biomolecular screening.

[4]  R. Neubig,et al.  Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423. , 2010, Bioorganic & medicinal chemistry letters.

[5]  Erik Sahai,et al.  Myocardin-Related Transcription Factors and SRF are required for cytoskeletal dynamics, invasion and experimental metastasis , 2009, Nature Cell Biology.

[6]  N. Senzer,et al.  Transcription factors: their potential as targets for an individualized therapeutic approach to cancer , 2009, Cancer Gene Therapy.

[7]  B. Leslie,et al.  Identification of the cellular targets of bioactive small organic molecules using affinity reagents. , 2008, Chemical Society reviews.

[8]  Edward H. Kerns,et al.  Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization , 2008 .

[9]  Richard R. Neubig,et al.  CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling , 2007, Molecular Cancer Therapeutics.

[10]  C. V. Golen,et al.  RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility , 2006, Oncogene.

[11]  T. Mak,et al.  RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. , 2005, Genes & development.

[12]  S. Morris,et al.  Megakaryoblastic Leukemia 1, a Potent Transcriptional Coactivator for Serum Response Factor (SRF), Is Required for Serum Induction of SRF Target Genes , 2003, Molecular and Cellular Biology.

[13]  E. Sahai,et al.  ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. , 2003, Cancer cell.

[14]  E. Sahai,et al.  RHO–GTPases and cancer , 2002, Nature Reviews Cancer.

[15]  S. Merajver,et al.  RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. , 2000, Cancer research.

[16]  Eric S. Lander,et al.  Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.

[17]  C. Myers,et al.  Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. , 2000, Biochemical and biophysical research communications.

[18]  Shuh Narumiya,et al.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.

[19]  M. Poss,et al.  Automated Synthesis and Purification of Amides: Exploitation of Automated Solid Phase Extraction in Organic Synthesis , 1997 .

[20]  R. Treisman.  The serum response element. , 1992, Trends in biochemical sciences.